Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.

Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.

Item
http://www.wikidata.org/entity/Q34655439
Polypoidal Choroidal Vasculopathy in AsiansIntravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian populationRanibizumab for the treatment of wet AMD: a summary of real-world studies.Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy.Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy.Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia.Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan.Association of Genes in the High-Density Lipoprotein Metabolic Pathway with Polypoidal Choroidal Vasculopathy in Asian Population: A Systematic Review and Meta-Analysis.Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.Polypoidal Choroidal Vasculopathy.
P2860

Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.

Item
http://www.wikidata.org/entity/Q34655439
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@ast
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@en
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration
@nl
type
label
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@ast
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@en
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration
@nl
prefLabel
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@ast
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@en
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Effectiveness of intravitreal ...... opathy over a 1 year follow-up
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932